La catena delle opzioni mostra i dati chiave delle opzioni azionarie di FGI Industries a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per FGI Industries..

FGI Industries (NASDAQ:FGI) Azioni, Catena delle Opzioni

FGI Industries

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.

FGI Industries Ltd

Ratings for Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $18.6, a high estimate of $27.00, and a low estimate of $13.00. This current average has decreased by 9.0% from the previous average price target of $20.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1745262057_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Jamf Holding. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;------------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Raimo Lenschow &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $13.00&#x7C;$16.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $15.00&#x7C;$18.00 &#x7C; 
&#x7C;Hamza Fodderwala &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $14.00&#x7C;$16.00 &#x7C; 
&#x7C;Hamza Fodderwala &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $16.00&#x7C;$20.00 &#x7C; 
&#x7C;Joshua Reilly &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $25.00&#x7C;$25.00 &#x7C; 
&#x7C;Raimo Lenschow &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $16.00&#x7C;$17.00 &#x7C; 
&#x7C;Joey Marincek &#x7C;Citizens Capital Markets&#x7C;Lowers &#x7C;Market Outperform&#x7C; $27.00&#x7C;$30.00 &#x7C; 
&#x7C;David Hynes &#x7C;Canaccord Genuity &#x7C;Lowers &#x7C;Buy &#x7C; $19.00&#x7C;$21.00 &#x7C; 
&#x7C;David Hynes &#x7C;Canaccord Genuity &#x7C;Maintains &#x7C;Buy &#x7C; $21.00&#x7C;$21.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Announces &#x7C;Overweight &#x7C; $20.00&#x7C;- &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Jamf Holding. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Jamf Holding compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Jamf Holding's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Jamf Holding's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/JAMF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Jamf Holding analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Jamf Holding</h2>
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.
<h3>Financial Insights: Jamf Holding</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Jamf Holding's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 8.18%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Jamf Holding's net margin is impressive, surpassing industry averages. With a net margin of -10.08%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Jamf Holding's ROE excels beyond industry benchmarks, reaching -2.29%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -1.04%, the company showcases effective utilization of assets.
Debt Management: Jamf Holding's debt-to-equity ratio is below the industry average at 0.52, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

JAMF

What Analysts Are Saying About Jamf Holding Stock

Analysts' ratings for Teradata (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $29.0, a high estimate of $37.00, and a low estimate of $22.00. Experiencing a 12.65% decline, the current average is now lower than the previous average price target of $33.20. 
<img src="https://www.benzinga.com/files/images/story/2025/1745262049_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Teradata among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Raimo Lenschow &#x7C;Barclays &#x7C;Lowers &#x7C;Underweight &#x7C; $22.00&#x7C;$25.00 &#x7C; 
&#x7C;Matthew Hedberg &#x7C;RBC Capital &#x7C;Lowers &#x7C;Sector Perform &#x7C; $29.00&#x7C;$32.00 &#x7C; 
&#x7C;Howard Ma &#x7C;Guggenheim &#x7C;Lowers &#x7C;Buy &#x7C; $37.00&#x7C;$42.00 &#x7C; 
&#x7C;Chirag Ved &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;Outperform &#x7C; $32.00&#x7C;$37.00 &#x7C; 
&#x7C;Raimo Lenschow &#x7C;Barclays &#x7C;Lowers &#x7C;Underweight &#x7C; $25.00&#x7C;$30.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Teradata. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Teradata compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Teradata's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TDC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Teradata analyst ratings.</a>
<h2>Delving into Teradata's Background</h2>
Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.
<h3>Teradata: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: Teradata's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -10.5%. This indicates a decrease in top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Teradata's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 6.11%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 19.38%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Teradata's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.49% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Teradata's debt-to-equity ratio stands notably higher than the industry average, reaching 4.33. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Teradata: 5 Analysts Share Their Views

National Bank Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBHC#NYSE">NBHC</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect National Bank Holdings to report an earnings per share (EPS) of $0.75.
The announcement from National Bank Holdings is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.09, leading to a 3.03% drop in the share price on the subsequent day.
Here's a look at National Bank Holdings's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.77</td>
<td>0.75</td>
<td>0.74</td>
<td>0.76</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.86</td>
<td>0.86</td>
<td>0.68</td>
<td>0.82</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.0%</td>
<td>8.0%</td>
<td>-5.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745262047_0.png" alt="eps graph" />
<h3>Performance of National Bank Holdings Shares</h3>
Shares of National Bank Holdings were trading at $35.55 as of April 18. Over the last 52-week period, shares are up 1.55%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/NBHC/earnings">To track all earnings releases for National Bank Holdings visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

NBHC

A Peek at National Bank Holdings's Future Earnings

Talos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Talos Energy, presenting an average target of $13.67, a high estimate of $20.00, and a low estimate of $12.00. Experiencing a 12.26% decline, the current average is now lower than the previous average price target of $15.58. 
<img src="https://www.benzinga.com/files/images/story/2025/1745262042_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Talos Energy by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Tim Rezvan &#x7C;Keybanc &#x7C;Lowers &#x7C;Overweight &#x7C; $12.00&#x7C;$16.00 &#x7C; 
&#x7C;Nitin Kumar &#x7C;Mizuho &#x7C;Lowers &#x7C;Outperform &#x7C; $12.00&#x7C;$15.00 &#x7C; 
&#x7C;Arun Jayaram &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $12.00&#x7C;$14.00 &#x7C; 
&#x7C;Paul Diamond &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $12.00&#x7C;$14.50 &#x7C; 
&#x7C;Arun Jayaram &#x7C;JP Morgan &#x7C;Raises &#x7C;Neutral &#x7C; $14.00&#x7C;$13.00 &#x7C; 
&#x7C;Mike Scialla &#x7C;Stephens &amp; Co. &#x7C;Lowers &#x7C;Overweight &#x7C; $20.00&#x7C;$21.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Talos Energy. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Talos Energy compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Talos Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Talos Energy's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TALO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Talos Energy analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Get to Know Talos Energy Better</h2>
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
<h3>Talos Energy: A Financial Overview</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Talos Energy's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 26.04%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.
Net Margin: Talos Energy's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -13.3%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -2.31%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -1.02%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Talos Energy's debt-to-equity ratio is below the industry average at 0.45, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TALO

Deep Dive Into Talos Energy Stock: Analyst Perspectives (6 Ratings)

Ratings for Dayforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAY#NYSE">DAY</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $75.0, along with a high estimate of $95.00 and a low estimate of $55.00. Highlighting a 10.0% decrease, the current average has fallen from the previous average price target of $83.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1745262034_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Dayforce. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Raimo Lenschow &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $61.00&#x7C;$69.00 &#x7C; 
&#x7C;Arvind Ramnani &#x7C;Mizuho &#x7C;Lowers &#x7C;Outperform &#x7C; $80.00&#x7C;$95.00 &#x7C; 
&#x7C; Allan Verkhovski &#x7C;Scotiabank &#x7C;Lowers &#x7C;Sector Perform &#x7C; $55.00&#x7C;$72.00 &#x7C; 
&#x7C;Brad Reback &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $85.00&#x7C;$90.00 &#x7C; 
&#x7C; Allan Verkhovski &#x7C;Scotiabank &#x7C;Lowers &#x7C;Sector Perform &#x7C; $72.00&#x7C;$75.00 &#x7C; 
&#x7C;Raimo Lenschow &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $69.00&#x7C;$80.00 &#x7C; 
&#x7C;Scott Berg &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $95.00&#x7C;$95.00 &#x7C; 
&#x7C;Samad Samana &#x7C;Jefferies &#x7C;Lowers &#x7C;Hold &#x7C; $75.00&#x7C;$80.00 &#x7C; 
&#x7C;Arvind Ramnani &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $83.00&#x7C;$94.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Dayforce. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dayforce compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Dayforce's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Dayforce's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DAY/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Dayforce analyst ratings.</a>
<h2>Get to Know Dayforce Better</h2>
Dayforce provides payroll and human capital management solutions targeting clients with 100-100,000 employees. Following the 2012 acquisition of Dayforce, Dayforce pivoted away from its legacy on-premises Bureau business to become a cloud HCM provider. As of fiscal 2022, about 80% of group revenue was derived from the flagship Dayforce platform geared toward enterprise clients. The remaining revenue is about evenly split between cloud platform Powerpay, targeting small businesses in Canada, and legacy Bureau products.
<h3>Understanding the Numbers: Dayforce's Finances</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Dayforce's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 16.39%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Dayforce's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 2.32%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 0.42%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Dayforce's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.13%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Dayforce's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.48.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Dayforce In The Eyes Of 9 Experts

Elanco Animal Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) short percent of float has fallen 4.21% since its last report. The company recently reported that it has 16.33 million shares sold short, which is 4.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.47 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Elanco Animal Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745262029_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Elanco Animal Health has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Elanco Animal Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Elanco Animal Health's peer group average for short interest as a percentage of float is 3.85%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

ELAN

What Does the Market Think About Elanco Animal Health?

Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Sun Communities, presenting an average target of $141.75, a high estimate of $150.00, and a low estimate of $135.00. A 0.64% drop is evident in the current average compared to the previous average price target of $142.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1745262027_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Sun Communities. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Aaron Hecht &#x7C;JMP Securities &#x7C;Lowers &#x7C;Market Outperform&#x7C; $140.00&#x7C;$150.00 &#x7C; 
&#x7C;Anthony Hau &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $135.00&#x7C;$142.00 &#x7C; 
&#x7C;Peter Abramowitz &#x7C;Jefferies &#x7C;Announces &#x7C;Buy &#x7C; $150.00&#x7C;- &#x7C; 
&#x7C;Anthony Hau &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $142.00&#x7C;$136.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Sun Communities. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Sun Communities compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Sun Communities's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Sun Communities's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SUI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Sun Communities analyst ratings.</a>
<h2>Get to Know Sun Communities Better</h2>
Sun Communities is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently owns a portfolio of 645 properties, which includes 341 manufactured housing communities, 166 residential vehicle communities, and 138 marina properties. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.
<h3>Unraveling the Financial Story of Sun Communities</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Positive Revenue Trend: Examining Sun Communities's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 2.59% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Sun Communities's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -30.08%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Sun Communities's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -3.07%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Sun Communities's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -1.32%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Sun Communities's debt-to-equity ratio is below the industry average. With a ratio of 1.04, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Sun Communities Through The Eyes Of 4 Analysts

Carvana's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) short percent of float has fallen 9.54% since its last report. The company recently reported that it has 7.99 million shares sold short, which is 6.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.51 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Carvana Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745262024_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Carvana has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Carvana's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Carvana's peer group average for short interest as a percentage of float is 11.19%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CVNA

Looking Into Carvana's Recent Short Interest

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Banner (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANR#NASDAQ">BANR</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $73.8, along with a high estimate of $82.00 and a low estimate of $65.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 2.89%. 
<img src="https://www.benzinga.com/files/images/story/2025/1745262020_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A clear picture of Banner's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Andrew Terrell &#x7C;Stephens &amp; Co. &#x7C;Maintains &#x7C;Overweight &#x7C; $73.00&#x7C;$73.00 &#x7C; 
&#x7C;David Feaster &#x7C;Raymond James &#x7C;Lowers &#x7C;Outperform &#x7C; $65.00&#x7C;$77.00 &#x7C; 
&#x7C;Kelly Motta &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $73.00&#x7C;$75.00 &#x7C; 
&#x7C;Jeffrey Rulis &#x7C;DA Davidson &#x7C;Raises &#x7C;Neutral &#x7C; $76.00&#x7C;$73.00 &#x7C; 
&#x7C;Andrew Terrell &#x7C;Stephens &amp; Co. &#x7C;Maintains &#x7C;Overweight &#x7C; $82.00&#x7C;$82.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Banner. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Banner compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Banner's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Banner's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BANR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Banner analyst ratings.</a>
<h2>Get to Know Banner Better</h2>
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
<h3>Banner: Financial Performance Dissected</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Banner's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -0.77%. This indicates a decrease in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Banner's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 28.61%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Banner's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.5%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Banner's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.28%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Banner's debt-to-equity ratio is below the industry average at 0.27, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BANR

Analyst Expectations For Banner's Future

LTC Properties's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTC#NYSE">LTC</a>) short percent of float has risen 14.91% since its last report. The company recently reported that it has 2.15 million shares sold short, which is 7.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.28 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>LTC Properties Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745262019_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for LTC Properties has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing LTC Properties's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, LTC Properties's peer group average for short interest as a percentage of float is 6.67%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on LTC Properties?

In the current session, Ovintiv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) is trading at $33.06, after a 2.25% decrease. Over the past month, the stock decreased by 26.37%, and in the past year, by 38.89%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1745262019_0_0.png" alt="Past Year Chart" />

<h3>How Does Ovintiv P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 27.12 in the Oil, Gas &amp; Consumable Fuels industry, Ovintiv Inc. has a lower P/E ratio of 8.03. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1745262019_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

News

Intraday Update

Markets

A Look Into Ovintiv Inc's Price Over Earnings

Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) shares are trading lower Monday after the Federal Trade Commission (FTC) filed a lawsuit against the company related to its <a href="https://www.benzinga.com/news/25/04/44904848/ftc-takes-action-against-uber-for-deceptive-billing-and-cancellation-practices-says-company-enrolled">Uber One subscription service</a>. 
What To Know: In a lawsuit filed on Monday, the FTC alleged that Uber engaged in <a href="https://www.ftc.gov/news-events/news/press-releases/2025/04/ftc-takes-action-against-uber-deceptive-billing-cancellation-practices">several deceptive practices</a>, including charging consumers for its Uber One subscription without their consent, failing to deliver on promised savings and making it difficult for consumers to cancel the service despite &#8220;cancel anytime&#8221; promises.
"Americans are tired of getting signed up for unwanted subscriptions that seem impossible to cancel. The Trump-Vance FTC is fighting back on behalf of the American people. Today, we're alleging that Uber not only deceived consumers about their subscriptions, but also made it unreasonably difficult for customers to cancel," said FTC chairman Andrew Ferguson.
The lawsuit states that customers were automatically charged before their free trials ended, despite company promises that customers could cancel during the trial period. The FTC noted that users may need to navigate up to 23 screens and complete up to 32 steps to cancel their subscriptions. The lawsuit also said customers were wrongly promised $25 in monthly savings, even though the subscription cost, which can reach $9.99 per month, was not factored into that amount.
See Also: <a href="https://www.benzinga.com/general/education/25/04/44858177/uber-ceo-dara-khosrowshahi-says-the-two-college-courses-are-absolute-necessity-for-c-suite-aspiring-leaders">Uber CEO Dara Khosrowshahi Says The Two College Courses Are &#8216;Absolute Necessity&#8217; For C-Suite-Aspiring Leaders</a>
The FTC alleged that the company's deceptive billing and cancellation practices violate the FTC Act and the Restore Online Shoppers' Confidence Act (ROSCA). 
An Uber spokesperson told Benzinga that the company is &#8220;disappointed&#8221; that the FTC is pursuing the lawsuit, but is &#8220;confident&#8221; that the courts will side with the company.
"We are disappointed that the FTC chose to move forward with this action, but are confident that the courts will agree with what we already know: Uber One's sign-up and cancellation processes are clear, simple, and follow the letter and spirit of the law. Uber does not sign up or charge consumers without their consent, and cancellations can now be done anytime in-app and take most people 20 seconds or less,&#8221; an Uber spokesperson said.
UBER Price Action: <a href="http://benzinga.com/quote/uber">Uber shares </a>were down 4.18% at $72.10 at the time of publication Monday. According to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Uber shares are up nearly 20% year-to-date. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44857710/google-faces-a-mammoth-66-billion-lawsuit-in-the-uk-over-suspected-market-dominance-abuse">Google Faces A Mammoth $6.6 Billion UK Class Action Lawsuit Over Reported Ad Price Inflation, Market Abuse</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/JHVEPhoto">JHVEPhoto</a>/ Shutterstock.

Legal

Movers

UBER

Uber Stock Skids After FTC Files Lawsuit Alleging 'Deceptive' Practices

GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) is scheduled to release its first quarter 2025 financial results on April 23, 2025.
As per data from Benzinga Pro, analysts expect adjusted earnings per share of 42 cents with <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">sales of $7.54 billion</a>.
BofA Securities analyst Andrew Obin writes, &#8220;We expect GE Vernova to be one of the few companies in our coverage to reiterate 2025 guidance ($36-$37bn revenue, high-single-digit adj. EBITDA margin).&#8221;
He adds peer Siemens Energy AG&#8217;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SMEGF#OTC">SMEGF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SMNEY#OTC">SMNEY</a>) March quarter results and FY25 guidance raise add to conviction.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44801588/bofa-sees-mostly-inline-q1-for-industrials-highlights-3m-jci-ge-vernova-as-top-picks" rel="noreferrer noopener">BofA Sees Mostly Inline Q1 For Industrials, Highlights 3M, JCI, GE Vernova As Top Picks</a>
&#8220;We believe an inline quarter and maintained 2025 guidance would be enough to drive a relief rally in GEV shares.&#8221;
BofA Securities forecasts a 1Q25 adjusted EBITDA of $0.3 billion, which aligns with the consensus.
The analyst reiterates a Buy rating with a price target of $485.
Earlier this month, GE Vernova announced its plan to supply seven high-efficiency 7HA.02 gas turbines capable of running on hydrogen,<a href="https://www.benzinga.com/25/04/44628044/ge-vernovas-gas-turbines-fuel-10b-data-center-project-in-pennsylvania" target="_blank" rel="noreferrer noopener"> with initial deliveries set for 2026</a>.
This transformation aims to support the increasing demand for artificial intelligence and high-performance computing from leading technology companies driving America&#8217;s digital future.
Analyst Obin adds that during recent earnings calls, U.S. electric utilities said it&#8217;s getting harder to secure gas turbines because there are fewer available production slots. They also noted that turbine prices are rising and companies are now being charged again to reserve manufacturing slots.
BofA Securities writes the recent order announcements (e.g., 4.5 gigawatt order) are positive.
Siemens Energy&#8217;s total orders rose 52% y/y on an organic basis, or a 1.45x book-to-bill.
BofA Securities sees &#8220;tariff exposure as manageable and views GEV as a beneficiary of U.S. deregulation efforts in power generation.&#8221;
GE Vernova spends about $20 billion on materials, which accounts for 55%-60% of its product costs. Only about 5% of that comes from imports — mostly from Mexico, with smaller amounts from Canada and China.
Tariffs on steel and aluminum are expected to have a limited impact, estimated at under $200 million.
Most of GEV&#8217;s Vernova service contracts last around 15 years and include inflation protections.
Equipment contracts are shorter but include large upfront and milestone payments. GE Vernova also uses strategies such as hedging, supply agreements and raw material stockpiling to reduce tariff-related costs.
Recent U.S. deregulation efforts are seen as a boost for natural gas power.
These include fast-tracking new power projects, revisiting emissions rules and reviewing state-level greenhouse gas regulations that affect interstate issues.
GEV Price Action: GE Vernova stock is down 4.69% at $308.39 at publication Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/04/44902787/chevron-totalenergies-fire-up-ballymore-deepwater-gulf-project-targeting-150-million-barrels-over-life" target="_blank" rel="noreferrer noopener">Chevron &amp; TotalEnergies Fire Up Ballymore: Deepwater Gulf Project Targeting 150 Million Barrels Over Life</a></li>
</ul>
Photo: GE Vernova&#8217;s onshore wind turbine, Courtesy GE Vernova

Analyst Color

Large Cap

Guidance

General

SMEGF

SMNEY

BofA Sees Tariff Impact As Minimal On GE Vernova Ahead Of Earnings

Bank of America Securities analyst Brad Sills maintained a Buy rating on Salesforce, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a <a href="https://www.benzinga.com/quote/CRM/analyst-ratings" target="_blank" rel="noreferrer noopener">price target of $350</a> on Monday.
In Sills&#8217; January report, the analyst outlined the case for Agentforce to drive incremental 1% to 2% points of cRPO growth as early as the second half of fiscal 2026.
The choppier macro since January likely pushes this to the first half of fiscal 2027.
Also Read: <a href="https://www.benzinga.com/news/25/03/44383229/salesforces-growth-path-analyst-predicts-28-2-billion-free-cash-flow-by-2031-but-tariffs-could-delay-target" target="_blank" rel="noreferrer noopener">Salesforce&#8217;s Growth Path: Analyst Predicts $28.2 Billion Free Cash Flow By 2031, But Tariffs Could Delay Target</a>
However, Sills remains bullish on Agentforce, given the strength in Data Cloud ($900 million ARR in the fiscal fourth quarter of 2025, up from $400 million in the fiscal fourth quarter of 2024).
Data Cloud is a leading indicator for Agentforce, given channel feedback that the primary use case is data preparation for Agentforce.
Sills conducted channel checks with key SIs to help inform some of these views.
The analyst noted two key deployment phases for Agentforce. They include data preparation (from 4 to 5 months) and agent development and testing (from 6 to 7 weeks).
To arrive at an Agentforce deployment that is material enough to drive meaningful conversation volumes, he noted that a customer would need 2 or 3 agents in production. These can be developed concurrently if the resources are available.
Concurrent production is likely to occur after the deployment of the first agent. In short, it is a six to seven-month cycle from data preparation to deployment of agents at a level where volumes are &#8216;spinning the meter&#8217; materialistically.
Commentary from partners suggests that the ROI for Agentforce is still evolving based on use cases.
Based on current use cases, 50 cents to $1 per conversation is deemed a reasonable price, he says. It&#8217;s consistent with Sills&#8217; model assumptions for 50 cents to 60 cents.
Key use cases evolving for Service Cloud include shipment tracking, product information retrieval, and renewal sales automation. These use cases represent a closer to 100% case deflection rate.
Agentforce is not yet able to automate more complex use cases. Such cases include direct interaction with prospects and providing investment advice. However, with more learning, added use cases and higher deflection rates are possible over time.
Price Action:&nbsp;CRM shares are trading lower by 4.93% to $235.09 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/04/44873349/openai-and-softbanks-stargate-considers-major-uk-investment-to-fuel-ai-growth" target="_blank" rel="noreferrer noopener">OpenAI And SoftBank&#8217;s Stargate Considers Major UK Investment To Fuel AI Growth</a></li>
</ul>
Image: Shutterstock

Price Target

Reiteration

Tech

Salesforce's Agentforce AI, Data Cloud Strengthen Long-Term Growth Potential: Analyst

Food safety solutions provider Neogen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOG#NASDAQ">NEOG</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Monday</a> after selling its Cleaners &amp; Disinfectants Business.
The company has finalized an agreement to divest its worldwide cleaners and disinfectants division to Kersia Group, a leading company in hygiene and biosecurity solutions, in a cash transaction valued at $130 million.
The agreement includes additional contingent payments based on the business's future performance. The transaction, subject to regulatory approval, is expected to conclude in the first quarter of FY26.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/44895043/target-rolls-out-standalone-flower-brand-good-little-garden" rel="noreferrer noopener">Target Rolls Out Standalone Flower Brand ‘Good Little Garden'</a>
"The sale of our cleaners and disinfectants business further focuses Neogen on food safety diagnostics and continuing to build on our leadership position in what we believe is an attractive end market with long-term tailwinds," said President and CEO of Neogen, John Adent.
"We expect Kersia's prioritization of investment and growth in the biosecurity market will benefit the business and provide sharpened strategic focus to maximize its potential for continued growth."
Proceeds from the sale will enable Neogen to eliminate its $100 million revolving credit debt, following a recent refinancing move.
The company expects the transaction to improve profit margins and lower its net leverage ratio by roughly 0.4x on a pro forma basis.
Neogen's disinfectant and cleaning product line, which brings in about $60 million in yearly revenue, supports various livestock markets such as poultry, swine, and ruminants.
Price Action: NEOG shares traded higher by 7.14% at $4.71 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44897010/chipotle-to-open-first-mexico-restaurant-by-2026" target="_blank" rel="noreferrer noopener">Chipotle To Open First Mexico Restaurant By 2026</a></li>
</ul>

Asset Sales

NEOG

Testing Firm Neogen Offloads Cleaners Division To Kersia In $130 Million Deal

Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) shares are trading lower by 2.2% to $36.60 during Monday&#8217;s session amid overall market weakness. The company last week reported first-quarter fiscal 2025 results, with results that <a href="https://www.benzinga.com/news/earnings/25/04/44811593/bank-of-america-ceo-says-consumer-continues-to-spend-and-maintain-healthy-credit-quality-sticks-to-annual-outlook">topped Wall Street expectations</a>. 
The bank posted net income of $7.4 billion, up from $6.7 billion a year earlier, with earnings per share of 90 cents, beating the consensus estimate of 81 cents. Revenue rose 6% to $27.37 billion, driven by growth in both noninterest and net interest income.
Bank of America's Consumer and Global Banking divisions posted slight profit declines, while Global Markets and Wealth Management showed gains. Credit loss provisions rose 12% to $1.48 billion. The CET1 capital ratio slipped to 11.8%, though book value per share rose 8% to $36.39.
CEO Brian Moynihan emphasized consumer resilience and reaffirmed the bank's long-term strategy, but analysts noted rising macro risks and revised down forecasts, potentially contributing to the stock's decline despite the otherwise strong quarter.
Read Also: <a href="https://www.benzinga.com/25/04/44896337/teslas-q1-test-drive-will-earnings-steer-tesla-stock-out-of-the-ditch">Tesla Q1 Test Drive: Will Earnings Steer The Stock Out Of The Ditch?</a>
What Else: However, investor sentiment has been soured after Federal Reserve Chair Jerome Powell last week <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44848474/fed-chair-powell-says-tariffs-lead-to-temporary-rise-in-inflation">warned of heightened inflation risks</a> and weakening growth tied to new U.S. trade tariffs. Powell's remarks Wednesday pointed to &#8220;notable deterioration&#8221; in consumer and business sentiment, adding uncertainty to the macro outlook.
The <a href="https://www.benzinga.com/government/regulations/25/04/44896834/dollar-hits-3-year-lows-us-stocks-tumble-as-trump-threatens-to-fire-powell-contrarians-of-the-world-unite">dollar sank Monday</a> amid fears President&nbsp;Donald Trump&nbsp;could move to oust Federal Reserve Chair&nbsp;Jerome Powell&nbsp;before his term expires in May 2026.
Read Also: <a href="https://www.benzinga.com/government/regulations/25/04/44896834/dollar-hits-3-year-lows-us-stocks-tumble-as-trump-threatens-to-fire-powell-contrarians-of-the-world-unite">Dollar Hits 3-Year Lows, US Stocks Tumble As Trump Threatens To Fire Powell: &#8216;Contrarians Of The World, Unite!&#8217;</a>
Investors can gain exposure to&nbsp;BAC by&nbsp;investing&nbsp;in the Financial Select Sector SPDR Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NASDAQ">XLF</a>).
<h2 class="wp-block-heading">How To Buy BAC Stock</h2>
By now you're likely curious about how to participate in the market for Bank of America &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Bank of America, which is trading at $36.64 as of publishing time, $100 would buy you 2.73 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BAC has a 52-week high of $48.08 and a 52-week low of $36.60.

What's Going On With Bank Of America (BAC) Shares?

Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) are trading lower Monday amid broader market weakness following cautious comments from Federal Reserve Chair Jerome Powell <a href="https://www.benzinga.com/25/04/44866378/whats-going-on-with-palantir-stock-today">last week</a> and President Donald Trump&#8216;s <a href="https://www.benzinga.com/government/regulations/25/04/44896834/dollar-hits-3-year-lows-us-stocks-tumble-as-trump-threatens-to-fire-powell-contrarians-of-the-world-unite">criticism of Powell.</a>
What To Know: On Wednesday, Powell warned that tariffs could push inflation higher and said the economy is showing signs of slowing, which spooked investors and raised concerns about future federal and commercial spending—key revenue sources for Palantir.
This drop comes despite several major developments for the company over the past month. Palantir was named in reports linking it to President Trump's proposed missile defense system, the "Golden Dome," alongside SpaceX and defense firm Anduril. Around the same time, the company announced a new partnership with Anthropic to bring its Claude AI model to U.S. government agencies through Palantir's FedStart platform.
Palantir also closed a fast-tracked <a href="https://www.benzinga.com/content/44836938/nato-deal-sparks-4-jump-in-palantir-stock-whats-next">deal with NATO</a> for its Maven Smart System NATO (MSS NATO), a military AI platform designed to support intelligence and battlefield operations. The deal went from concept to signed contract in six months, a fast timeline for NATO procurement.
Despite these wins, Morgan Stanley cut its price target on Palantir from $95 to $90 while maintaining an Equal-Weight rating. The stock is still up over 300% in the past year but is now reacting more to macroeconomic risks than individual contract wins.
The stock remains technically strong in some areas, trading above its 20- and 200-day moving averages, but it dipped below its 50-day average and is showing mixed momentum signals. 
PLTR Price Action: Palantir shares were down 4.52% at $89.54 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0421"><img loading="lazy" decoding="async" width="1024" height="532" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21140909/Screenshot-2025-04-21-at-14.08.51-1024x532.png" alt="" class="wp-image-880396" style="width:422px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21140909/Screenshot-2025-04-21-at-14.08.51-1024x532.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21140909/Screenshot-2025-04-21-at-14.08.51-300x156.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21140909/Screenshot-2025-04-21-at-14.08.51-768x399.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21140909/Screenshot-2025-04-21-at-14.08.51-1536x798.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21140909/Screenshot-2025-04-21-at-14.08.51.png 1541w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44904179/wall-street-sinks-dollar-slides-as-trump-ramps-up-fed-attacks-whats-driving-markets-monday">Wall Street Sinks, Dollar Slides As Trump Ramps Up Fed Attacks: What&#8217;s Driving Markets Monday?</a></li>
</ul>
Image Via Shutterstock.

PLTR

Palantir Stock Tumbles As Broader Tech Weakens: What's Going On?

Gilead Sciences, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) on Monday released topline results from the Phase 3 ASCENT-04/KEYNOTE-D19 study of Trodelvy&nbsp;(sacituzumab govitecan-hziy) plus Merck &amp; Co Inc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) <a href="https://www.benzinga.com/general/health-care">Keytruda&nbsp;(pembrolizumab)</a>.
The trial demonstrated that Trodelvy plus Keytruda&nbsp;significantly improved progression-free survival (PFS) compared to Keytruda and chemotherapy in patients with inoperable (unresectable) locally advanced or metastatic triple-negative breast cancer (mTNBC) whose tumors express <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44895548/trodelvy-plus-keytruda-demonstrates-a-statistically-significant-and-clinically-meaningful-improvem" rel="noreferrer noopener">PD-L1 (CPS ≥ 10)</a>.
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in PFS.
Also Read: <a href="https://www.benzinga.com/general/biotech/25/03/44395415/trump-administration-weighs-deep-cuts-to-domestic-hiv-prevention-programs-gilead-stock-slides" target="_blank" rel="noreferrer noopener">Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides</a>
The safety profile of Trodelvy plus Keytruda in the ASCENT-04 study was consistent with each agent&#8217;s known safety profile. No new safety signals were identified with the combination.
&#8220;These findings are the first to show the transformative potential of an antibody-drug conjugate combined with an immuno-oncology agent in early treatment lines of metastatic breast cancer,&#8221; said Dietmar Berger Chief Medical Officer, Gilead Sciences.
Overall survival (OS) is a key secondary endpoint and was not mature at the time of the PFS primary analysis. However, in the ASCENT-04 study, there was an early trend in improvement for OS with Trodelvy plus Keytruda.
Gilead will continue to monitor OS outcomes, with ongoing patient follow-up and further analyses planned.
Detailed results from the study will be presented at a future medical meeting and discussed with regulatory authorities.
The use of Trodelvy plus Keytruda in patients with previously untreated PD-L1+ metastatic TNBC is investigational, and the safety and efficacy of this use have not been established.
Trodelvy is the only approved Trop-2-directed antibody-drug conjugate (ADC) that has demonstrated meaningful survival advantages in two types of metastatic breast cancers: 2L+ mTNBC and pre-treated HR+/HER2- mBC.
It is a Category 1 preferred treatment for both indications per the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines) and the only ADC with an ESMO Magnitude of Clinical Benefit Scale (MCBS) rating of 5 for mTNBC.
Trodelvy also has an MCBS rating of 4 for women with HR+/HER2- mBC.
Currently, Gilead has three ongoing Phase 3 studies investigating Trodelvy across HER2- (IHC 0, IHC 1+ or IHC 2+/ISH–) mBC, including the upcoming ASCENT-03 pivotal trial in 1L mTNBC patients who are not candidates for PD-L1 based therapy, the ASCENT-05 pivotal trial in patients with early-stage TNBC, and the ASCENT-07 pivotal trial in patients with HR+/HER2- mBC who have received endocrine therapy.
Trodelvy is also being investigated in additional Phase 3 studies in other disease settings, including lung and gynecological cancers.
Price Action: GILD stock is down 0.46% at $104.06 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44902345/upexi-raises-100-million-to-expand-crypto-ventures-stock-soars" target="_blank" rel="noreferrer noopener">Upexi Raises $100 Million To Expand Crypto Ventures, Stock Soars</a></li>
</ul>
Photo by Michael Moloney via Shutterstock

Biotech

Health Care

GILD

Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="1024" height="608" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21174035/image-13.png" alt="" class="wp-image-11210" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21174035/image-13.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21174035/image-13-300x178.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/21174035/image-13-768x456.png 768w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The image is AI-generated
Earnings estimates for the next 12 months are rising.
And earnings estimates for 2025 and 2026 have been coming down.
The above statements sound like they're in conflict. But they are actually two&nbsp;<a href="https://substack.com/redirect/0b428c4f-94a3-4eca-867a-9071583c8777?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">ways of communicating</a>&nbsp;the&nbsp;<a href="https://substack.com/redirect/a5308509-c43c-4f32-bf7f-4cbaa8184f4e?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">same information</a>. The differentiating factor: The passage of time.
Calendar year vs. NTM earnings estimates&nbsp;
We often hear analysts talk about earnings estimates based on&nbsp;calendar years. For example, coming into this year Wall Street strategists presented their&nbsp;<a href="https://substack.com/redirect/d2fcbbd5-785d-44cf-89cb-778917cbbd04?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">estimates for 2025 earnings</a>.
As time passes and information emerges,&nbsp;<a href="https://substack.com/redirect/22f4dde1-df4a-49a9-86c4-a3295477d6df?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">analysts will adjust those estimates</a>. Historically,&nbsp;<a href="https://substack.com/redirect/0188d832-2a15-4595-90b0-d82599b8c1ad?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">analysts tend</a>&nbsp;to gradually&nbsp;<a href="https://substack.com/redirect/48d4d293-0e8e-4b9c-8595-53393df0b0a3?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">revise down</a>&nbsp;these calendar year estimates. And so far,&nbsp;<a href="https://substack.com/redirect/82be0da4-a482-4567-94fd-a70e689559d6?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">this has been the case in 2025</a>.
However,&nbsp;<a href="https://substack.com/redirect/342af7c2-b95c-4bef-97d5-e237a475db0b?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">time can pass quickly</a>. And with calendar year estimates, what was once a discussion about future earnings can quickly become a discussion about past earnings.
For example, at the beginning of the year, 2025 earnings represented the next-12 months' (NTM) earnings. But it's April now, which means any discussion of 2025 earnings involves an old quarter, and any discussion of&nbsp;<a href="https://substack.com/redirect/8a401c08-d6f9-4731-8f55-3d98263a93bd?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">NTM earnings</a>&nbsp;involves a quarter in 2026.
Morgan Stanley's Michael Wilson shared a nice side-by-side visualization of this somewhat confusing dynamic. The chart on the left shows the S&amp;P 500's NTM earnings per share (EPS). As time passes, you can see NTM EPS move up as it continuously incorporates the higher earnings expected in future periods.
The chart on the right shows EPS estimates for 2025 and 2026 — static periods in time. As time passes, you can see how analysts' estimates have moved lower in recent months.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td></td>
<td><img loading="lazy" decoding="async" width="550" height="187" src="blob:https://contributor.benzinga.com/893e7645-3b3f-4da5-9f17-b06149334f44" /><a href="https://substack.com/redirect/efad4a0a-c4db-49a0-8c59-14336728409f?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener"></a></td>
<td></td>
</tr>
</tbody>
</table>
</figure>
NTM earnings estimates look good despite calendar year estimates coming down. (Source: Morgan Stanley)
"NTM EPS estimates continue to advance on the back of stronger 2026 EPS growth," Wilson observed. "However, NTM EPS may show signs of flattening in recent weeks as 2025/2026 estimates revise slightly lower (-1%)."
To be clear, both charts employ the same analysts' estimates for earnings. They just differ in the way they reflect the effect of the passage of time.
And the two charts are currently telling us that the promise of earnings growth on a rolling future basis is more than offsetting deteriorating expectations for static periods.
This is important&nbsp;<a href="https://substack.com/redirect/342af7c2-b95c-4bef-97d5-e237a475db0b?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">in the context of valuation metrics</a>&nbsp;like the&nbsp;<a href="https://substack.com/redirect/03d88312-205c-4fe0-bd16-37890cbc0883?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">forward price-earnings (P/E) ratio</a>. If earnings are expected to grow, then forward earnings (E) will rise as time passes. This leads to downward pressure on P/E ratios.
Be mindful in this uncertain environment&nbsp;
As&nbsp;<a href="https://substack.com/redirect/379e1d53-9bdd-4f7c-ac3f-c8c272798793?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">we discussed last week</a>, there are currently a lot of issues with analysts' earnings estimates.&nbsp;<a href="https://substack.com/redirect/99def433-1d70-418f-862d-84d02780ab03?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">Uncertainty is very high</a>, and there&#8217;s evidence that the&nbsp;<a href="https://substack.com/redirect/10ab8cb9-cce7-4aae-8f16-a8168741bcf3?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">earnings estimates</a>&nbsp;out there right now&nbsp;<a href="https://substack.com/redirect/379e1d53-9bdd-4f7c-ac3f-c8c272798793?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">are stale</a>.
But again, both visualizations are working off the same estimates. So if we believe the estimates for E is off, discussions about both NTM and calendar year estimates will similarly be off.
The bottom line: Be mindful about what you read and hear about earnings estimates. While it can be helpful to know what's going on with revisions in certain calendar years, the information for a particular year will become less relevant as time passes. This is why it's arguably more useful to look to NTM earnings because stock prices are&nbsp;<a href="https://substack.com/redirect/b700d46e-4ff3-40fa-997e-e505338cd526?j=eyJ1IjoiNThoaTNqIn0.oQOskqZ_hj7KyeETRBdER4rAvQcgl0VTn-sq5tqKUD0" target="_blank" rel="noreferrer noopener">heavily determined by expectations for the future</a>.

Equities

Opinion

Making Sense Of Seemingly Conflicting Statements About Earnings Estimates

APVO

Aptevo Therapeutics Shares Resume Trading

Press Releases

FGI INDUSTRIES ANNOUNCES FIRST QUARTER 2024 RESULTS CONFERENCE CALL DATE

FGI INDUSTRIES ANNOUNCES FIRST QUARTER 2024 RESULTS

FGI INDUSTRIES ANNOUNCES SECOND QUARTER 2024 RESULTS CONFERENCE CALL DATE

FGI INDUSTRIES ANNOUNCES SECOND QUARTER 2024 RESULTS

FGI INDUSTRIES ANNOUNCES THIRD QUARTER 2024 RESULTS CONFERENCE CALL DATE

FGI INDUSTRIES ANNOUNCES THIRD QUARTER 2024 RESULTS

FGI INDUSTRIES TO ATTEND THE BENCHMARK DISCOVERY ONE-ON-ONE INVESTOR CONFERENCE

FGI INDUSTRIES ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 RESULTS CONFERENCE CALL DATE

FGI INDUSTRIES ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 RESULTS

Alta Equipment Group Inc. Class A Common Stock

Alta Equipment Group

BioNexus Gene Lab

Euro Tech Holdings Company Limited - Ordinary Shares

Euro Tech Hldgs

EVI Industries

Hudson Technologies

iPower

Karat Packaging

Multi Ways Holdings Limited Ordinary Shares

Multi Ways Holdings

Marwynn Holdings

Simpple

Titan Machinery

ZKH Group Limited American Depositary Shares, each representing thirty-five (35) Class A Ordinary Shares

ZKH Group

Benchmark

Northland Capital Markets

Screenshot 2024-03-20 at 5.39.30 PM

Movers & Shakers

Interview

EFSH

INTERVIEW: Benzinga Sits Down With Diversified Holding Company 1847&#39;s (NYSE: EFSH) CEO To Discuss The Company&#39;s Wins, Its Strategies For Success And More

Comments

FGI Industries

FGI Industries (FGI) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO